Is Thymoglobulin or Rituximab the Cause of This Serum Sickness? A Case Report of Serum Sickness Dilemma and Literature Review
Serum sickness is an immune-complex-mediated systemic illness that can occur after treatment with monoclonal or polyclonal antibodies such as Rituxan (Rituximab) or antithymocyte globulin (Thymoglobulin), respectively. Since Rituximab is now being used as an adjuvant treatment for acute humoral reje...
Saved in:
Main Authors: | Amarpreet Sandhu, Antonia Harford, Pooja Singh, Eduardo Alas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/234515 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rituximab-induced serum sickness: Not so uncommon
by: Vikramraj K Jain
Published: (2018-01-01) -
Serum Sickness following Tetanus Toxoid Injection
by: Saja alhawal, et al.
Published: (2021-01-01) -
Homesick or Sick of Home?
by: Laura Luise Schultz
Published: (2025-01-01) -
THE Effects of Motivational Interviewing on Motion Sickness
by: Unal DEMIRTAS, et al.
Published: (2015-12-01) -
Glutamine Supplementation in Sick Children: Is It Beneficial?
by: Elise Mok, et al.
Published: (2011-01-01)